文献速递慢性静脉疾病

不同腔内热消融系统治疗大隐静脉反流的前瞻性对比研究

Prospective comparative study of different endovenous thermal ablation systems for treatment of great saphenous vein reflux.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-10-21

单中心前瞻性对比队列研究纳入153例(160条肢体)大隐静脉反流患者,比较节段性射频消融、1470nm径向光纤激光和1470nm外套管尖端光纤激光的疗效。三组1年闭合率93%-95%,无重大并发症,径向光纤激光组术后早期疼痛和静脉临床严重程度评分改善更优。

要点

  • 三种腔内热消融方式治疗大隐静脉反流1年闭合率均达93%-95%,安全性相当。
  • 1470nm径向光纤激光组术后1周静脉临床严重程度评分改善优于射频消融和外套管尖端光纤组。
  • 术后7天和30天生活质量评分改善径向光纤激光组优于射频消融组,7天优于外套管尖端光纤组。

核心结论

  • 三种腔内热消融方式治疗大隐静脉反流有效性和安全性相当。
  • 1470nm径向光纤激光在术后早期静脉临床严重程度评分、疼痛和生活质量生理维度评分方面表现更优。
  • 术后1年时三种方式的临床和生活质量获益相似。

研究设计与样本

  • 单中心前瞻性对比队列研究,纳入连续接受大隐静脉腔内热消融的患者。
  • 共153例患者(160条肢体),分为节段性射频消融组(53条肢体)、1470nm径向光纤激光组(55条肢体)和1470nm外套管尖端光纤激光组(52条肢体)。
  • 主要结局为临床成功,定义为无大隐静脉反流或再通及无手术相关并发症,于术后7天、30天和1年评估。

主要发现

  • 1年大隐静脉闭合率:射频消融组93%,径向光纤激光组93%,外套管尖端光纤激光组95%。
  • 术后无重大并发症,三组热诱导血栓发生率分别为4.4%、2.2%和4.4%(P > .5)。
  • 术后1周静脉临床严重程度评分径向光纤激光组改善优于射频消融组(P = .05)和外套管尖端光纤组(P = .002)。
  • 术后7天生活质量评分变化径向光纤激光组优于射频消融组(-14.3 ± 10.3 vs -7.9 ± 5.9;调整差异6.06;95%CI 1.57-10.55;P = .01)。
  • 术后30天生活质量评分变化径向光纤激光组优于射频消融组(-12 ± 8 vs -11.2 ± 7;调整差异5.5;95%CI 1.21-9.81;P = .02)。

临床怎么用

  • 三种腔内热消融方式均可用于大隐静脉反流的治疗,可根据设备和操作者偏好选择。
  • 若关注术后早期疼痛和生活质量改善,可优先考虑1470nm径向光纤激光。
  • 术后需监测热诱导血栓等并发症,尽管本研究中无重大并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of our study was to compare three different endovenous thermal ablation (EVTA) modalities in the treatment of great saphenous vein (GSV) incompetence. METHODS: We performed a single-center, prospective, comparative cohort study that included consecutive patients undergoing EVTA of the GSV. Patients were treated with either segmental radiofrequency ablation (sRFA) or endovenous laser ablation (EVLA) with a 1470-nm dual radial fiber or with a 1470-nm jacket-tip fiber. The clinical classification CEAP (clinical, etiologic, anatomic, pathophysiologic), 10-cm visual analog scale scores for pain, Venous Clinical Severity Scores (VCSSs), and chronic venous insufficiency quality-of-life questionnaire (CIVIQ-20) scores were recorded. The primary outcome was clinical success, which was defined as the absence of reflux or recanalization of the GSV and procedure-related complications, assessed at 7 and 30 days and 1 year postoperatively. The secondary outcomes were the assessment of postoperative pain using the VAS and improvement in the VCSSs and CIVIQ-20 scores. RESULTS: A total of 153 patients (160 limbs) had undergone sRFA (sRFA group; n = 53 limbs), 1470-nm radial fiber EVLA (EVLA-R group; n = 55 limbs), or 1470-nm jacket-tip fiber EVLA (EVLA-J group; n = 52 limbs). The patient demographics, CEAP clinical class, and intraoperative details were comparable among the three groups. The GSV occlusion rate at 1 year was 93% in the sRFA group, 93% in the EVLA-R group, and 95% in the EVLA-J group. No major complications were observed postoperatively. Endothermal heat-induced thrombosis was observed in 2 (4.4%), 1 (2.2%), and 2 (4.4%) patients in the sRFA, EVLA-R, and EVLA-J groups, respectively (P > .5). The VCSS showed greater improvement in the EVLA-R group at 1 week compared with that in the sRFA (P = .05) and EVLA-J (P = .002) groups. Changes in the CIVIQ-20 score were in favor of the EVLA-R group at 7 days (-14.3 ± 10.3 vs -7.9 ± 5.9; adjusted difference, 6.06; 95% confidence interval [CI], 1.57-10.55; P = .01) and 30 days (-12 ± 8 vs -11.2 ± 7; adjusted difference, 5.5; 95% CI, 1.21-9.81; P = .02) postoperatively compared with the sRFA group and at 7 days compared with the EVLA-J group (-14.3 ± 10.3 vs -9.6 ± 7.9; adjusted difference, -4.4; 95% CI, -9.06 to 0.22; P = .05). Analyzing the different components of the CIVIQ-20, pain, and physical scores showed a greater reduction in the EVLA-R group in the early postoperative period compared with that in the sRFA and EVLA-J groups. CONCLUSIONS: All three EVTA modalities showed equal effectiveness and safety for the treatment of GSV reflux. EVLA with the 1470-nm radial fiber showed better outcomes in terms of early postoperative VCSSs and pain and physical CIVIQ scores. The clinical and quality of life benefits were similar for all modalities at 1 year postoperatively.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Karathanos C, Spanos K, Batzalexis K, et al. Prospective comparative study of different endovenous thermal ablation systems for treatment of great saphenous vein reflux. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33099037. doi:10.1016/j.jvsv.2020.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。